MHRA Approves New Drug for Rare, Disabling Joint Tumour

Published Date: 17 Aug 2026

The MHRA approves a new selective kinase inhibitor that controls growth of debilitating tenosynovial giant cell tumours in young and middle-aged adults.

Read Full News

Latest News

Whole Person Approach to Pain Management for Vets in Hospice

This quality improvement project aims to support the uptake and utilization of nonpharmacological pain management interventions for veterans receiving inpatient hospice care.

Axial PsA Diagnosis: Applying AXIS Evidence in Practice

Dr Denis Poddubnyy discusses data from the AXIS study that inform his approach to diagnosing axial psoriatic arthritis.

Doc Sues Malpractice Insurer for Refusing to Settle Lawsuit

A South Carolina ob/gyn says MagMutual should have settled a patient’s malpractice lawsuit after a birth injury.

Cancer Pain Remains a Major Clinical Challenge

From nerve blocks to intrathecal systems, specialists say advanced pain strategies may help when standard analgesics fall short.

Outpatient Palliative Care Consult and End-of-Life Outcomes

This study evaluated the impact of outpatient palliative care consultation on Life-Sustaining Treatment note completion, hospice referral rates, and venue of death.

French Experts Say Medical Hypnosis May Ease ENT Procedures

Clinicians at a French hospital describe hypnosis as a complementary approach that may help patients in different age groups manage anxiety and pain during procedures.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Latest News

This quality improvement project aims to support the uptake and utilization of nonpharmacological pain management interventions for veterans receiving inpatient hospice care.

Dr Denis Poddubnyy discusses data from the AXIS study that inform his approach to diagnosing axial psoriatic arthritis.

A South Carolina ob/gyn says MagMutual should have settled a patient’s malpractice lawsuit after a birth injury.

From nerve blocks to intrathecal systems, specialists say advanced pain strategies may help when standard analgesics fall short.

This study evaluated the impact of outpatient palliative care consultation on Life-Sustaining Treatment note completion, hospice referral rates, and venue of death.

Clinicians at a French hospital describe hypnosis as a complementary approach that may help patients in different age groups manage anxiety and pain during procedures.

News All Time

Watch Out! A Coding Audit May Be Coming Your Way

Payers are stepping up their audit activities for medical practice and hospital billing and coding. Here’s how to avoid being a target.

How Scrubs (and Time) Quietly Stole the White Coat’s Mojo

They began as plain operating-room clothes. Now scrubs are healthcare’s default uniform, a big business, and even runway inspiration. How did the white coat go out of style?

Beyond the Scale: Men Turn to Cosmetic Clinics to Complete Weight-loss Transformation

As top-selling weight-loss drugs help more U.S. men slim down, a growing number are seeking cosmetic treatments for sagging skin, hair loss and dental issues to complete...

Deep Dive: SNRIs: One Mechanism, No Interchangeability

Milnacipran and its enantiomer, levomilnacipran, share a mechanism but not one approved indication. Alan Schatzberg, MD, on what that split means for prescribing.

States Tighten Private Equity Healthcare Oversight

Nearly a dozen states have recently enacted laws addressing private equity in healthcare, including ownership transparency and physician control, with more bills pending.

Mental Health Burden High Among PWH in Panama

Nearly 1 in 6 people living with HIV report moderate-to-severe depression and nearly 1 in 5 report high anxiety — both tied to discrimination, chronic pain, and difficulty with daily activities.

Are GLP-1 Drugs Now Kidney Drugs?

We file GLP-1s under "diabetes drugs" or "weight-loss drugs." Both labels are true. But data from the last 24 months show that these are kidney drugs.

Rewriting the Vaccine Schedule Without Science at the Table

Dr Daskalakis explains the confusion a recent executive order on vaccines can wrought, and why the MMR vaccine cannot simply be split into three shots.

How to Discuss Postmastectomy Numbness in a 20-Minute Visit

Dr Kristin Rojas gives clinicians practical and actionable tips on how to discuss postmastectomy numbness and intimacy with patients.

Is Chronic Pain Guidance Delivering What NICE Promised?

Pain specialists say patients still aren’t getting what NICE’s guidance promised — and access remains the real barrier.

Deep Dive: DOACs in 2026: Why the Incumbents Still Win

Two trials tried to beat DOACs on bleeding. One (phase 3) failed on efficacy; the other (phase 2b) left stroke prevention unproven. John Alexander, MD, on what that means for practice.

GLP-1s and Blinding Condition; Cyclosporiasis Source Found? Tylenol-Autism Lawsuits

Health news and commentary gathered by MedPage Today staff

Study Offers Reassurance to Women Considering Epidural During Labor

The BMJ offers more information on its effect in neonates

Oral Steroids After Tonsillectomy May Modestly Cut Kids' Pain

Clinical trial turns up small difference in scores but can't make definitive conclusions

Anaphylaxis During Surgery, an Anesthesiologist Explains

A look at the causes and treatment

Sodium Channel Blocker Cuts Post-Surgery Pain

Novel analgesic associated with significantly lower opioid use

Recommended News For You

Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria

'Sleep ALL night' program helps children with leukemia sleep better during treatment

Analysis of projected cancer rates in Canada by 2024.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

Simpler Screening Criteria Could Catch More Lung Cancers

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

Chiauranib Slows Platinum-Resistant Ovarian Cancer

Recommended Articles For You

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense 

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology 

Spatial Mapping of Tumor Cell States: Integrating Biology, Technology, and Clinical Practice 

The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chromatin organization linked to p53 tumor suppression mechanism

2.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

3.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

4.

New protein target discovered for childhood medulloblastomas

5.

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

1.

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs

2.

Public Health Through Cancer Survivorship Infrastructure at the Community Level

3.

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide 

4.

Coagulation Factor Consumption During Severe Inflammation: Mechanisms, Clinical Implications, and Advances

5.

Understanding Iron Saturation Levels in Your Blood 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

3.

Immunotherapy: A New Era in Cancer Treatment

4.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

5.

Diagnosis and Management in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot